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, potentially weakening the risk of Cu 2+ -induced TSE diseases. Our work sheds light on the
Introduction
Prion proteins (PrPs) are cell-surface Cu 2+ -binding glycoproteins that are responsible for prion diseases, the transmissible spongiform encephalopathies (TSEs) [1, 2] . TSEs are fatal neurodegenerative diseases that are associated with the conversion of α-helix-rich cellular PrP (PrP C ) into β-sheet-rich scrapie form (PrP Sc ) [1, [3] [4] [5] . The insoluble PrP Sc has been treated as the pathogenic agent for many years. However, growing investigations suggest that the infectious prion is probably the soluble oligomer, the intermediate of the conformational transformation from PrP C to PrP Sc [6] [7] [8] . Thus, the oligomerization of PrP C is believed to be a vital step in the pathogenic processes of prion diseases.
As an essential trace metal, copper plays fundamental roles in biological functions of the nervous system [9, 10] . The central nervous system has high level of copper, and the brain comprises 2% of the total body mass but containing 7.3% of total body copper [11, 12] . The imbalance of copper has been linked to neurodegenerative diseases, including prion diseases [13, 14] . Increasing evidence supports the participation of Cu 2+ in the pathogenic processes of prion diseases [15] [16] [17] . Previous studies showed that Cu 2+ -binding-induced protease resistance of PrP [18] [19] [20] [21] , and promoted conformational conversion of monomeric PrP C into neurotoxic PrP oligomer [22] . At acidic condition, Cu 2+ could promote the conversion of α-helical PrP C into β-sheet oligomer with neurotoxicity. Furthermore, the Cu 2+ -induced reactive oxygen species could also lead to conformational transition and aggregation of PrP [23] . Therefore, Cu 2+ -binding plays a vital role in the oligomerization process of PrP C .
Many mammals have been reported to be TSE-sensitive species with the potential of converting conformation of PrP from PrP C to PrP Sc , such as human, cattle, sheep, and mice [1, [24] [25] [26] . On the contrary, rabbits are one of the few species that are resistant to prion diseases and have a low susceptibility to be infected by PrP Sc [27] .
Previous studies have suggested that the TSE-resistance of rabbit is mostly due to multiple amino acid residues in the rabbit PrP [27] . Although the protein misfolding cyclic amplification technique could be applied to overcome the species barrier in rabbit [28] [29] [30] , rabbit is still one of the TSE-resistant species. Recent studies have demonstrated that the specific domains beyond PrP-H2H3 of rabbit remarkably affected the misfolding of rabbit PrP [31, 32] . The resistance of rabbits to TSEs is highly associated with the difficulty of the conformational conversion of rabbit PrP C (RaPrP C ) mostly due to the unique structural characteristics of RaPrP C [33, 34] . The local structures of the copper-binding globular regions of HuPrP C and RaPrP C have been accessed by X-ray absorption fine structure technique and X-ray absorption near-edge structure technique [35, 36] . 
Materials and Methods
Plasmid construction, protein expression, and purification
The gene fragment encoding either HuPrP C (91-230) or RaPrP C (91-228) was inserted into the vector pET-30a via NdeI and XhoI restriction sites and then transformed into Escherichia coli BL21(DE3) strain. The cells were cultured in 2× YT medium containing 0.05 mg/ml kanamycin at 37°C. When the A 600 nm reached between 0.8 and 1.0, 1.0 mM isopropyl-β-D-thiogalactoside was added and cells were grown for another 4 h. Then, cells were harvested by centrifugation at 9000 rpm for 4 min at 4°C, and re-suspended in the buffer (20 mM Tris, 2 mM EDTA, 150 mM NaCl, 100 μg/ml lysozyme, 0.1% Triton X-100, 1 mM PMSF, pH 7.4), followed by sonication for 30 min. After centrifugation at 11,000 rpm for 25 min at 4°C, the inclusion bodies were collected and washed with the buffer (20 mM Tris, 150 mM NaCl, 0.5% Triton X-100, 2 M NaCl, 4 M urea, pH 7.4). The resulting pellets were dissolved in the buffer (10 mM Tris, 100 mM Na 2 HPO 4 , 0.5% Triton X-100, 10 mM β-Mercaptoethanol, 6 M GdnHCl, pH 8.0) and refolded by dialysis using the buffer (10 mM Tris, 100 mM Na 2 HPO 4 , pH 8.0) with a linear gradient 6-0 M GdnHCl. The resulting protein solution was purified by FPLC on a 10/300 Superdex 75 column (GE Healthcare, Wisconsin, USA) with the elution buffer (20 mM NaOAc, 0.02% NaN 3 , pH 5.5). The protein purity was assessed by 15% sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The purified protein solution was concentrated by ultracentrifugation and the protein concentration was determined using NanoVue plus (GE Healthcare) at 280 nm with the extinction coefficient of 22 × 
Size exclusion chromatography
Size exclusion chromatography was performed using ÄKTA FPLC equipment (GE Healthcare). Five column volumes of elution buffer were used to equilibrate the column prior to the experiments. The flow rate was 0.4 ml/min and the protein elution was monitored by ultraviolet absorption at 280 nm.
Oligomeric prion preparation
The purified HuPrP C (91-230) and RaPrP C (91-228) proteins were diluted to 40 μM in the buffer (20 mM NaOAc, 150 mM NaCl, 0.02% NaN 3 , pH 4.0). The samples were kept in the thermostatic water bath at 37 and 42°C for 80 min without or with 40-480 μM of Cu(OAc) 2 , respectively. Products were further separated by 10/300 Superdex 75 column (GE Healthcare) for the subsequent experiments. Data were processed with the software Unicorn 5.2.
Isothermal titration calorimetry
The dissociation constant (K d ) and stoichiometry (N) of the interaction between Cu 2+ and PrP C was measured by ITC using an ITC200 calorimeter (GE Healthcare). Calorimetric titration of Cu
2+
to PrP C was performed at 25°C in acetate buffer (20 mM NaOAc, pH 5.5). Time between injections was 150 s. ITC data were analyzed by integrating the heat effects after the data were normalized to the amount of injected protein. Data fitting was conducted to determine the dissociation constant and stoichiometry based on a single-site binding model using the Origin software package (GE Healthcare).
CD spectroscopy
All CD spectra were recorded on a Jasco J-810 spectropolarimeter (Jasco, Tokyo, Japan) interfaced with a Peltier-type temperature control at 25°C. The reported spectra were an average of three consecutive scans and blanked with respective buffers. Far-UV CD spectra were collected in the wavelength range of 200-250 nm using 1-mm path length. The spectra were recorded in continuous scanning mode at a scanning rate of 50 nm/min with a step size of 0.2 nm and a bandwidth of 1 nm. To conduct urea-induced unfolding transition experiments, the range of urea concentrations up to 10 M was used with 0.5 M gradient. The Cu(OAc) 2 stock solution was added into the protein solution prior to titrating the stock solution of urea. For the experiments of metal binding to PrP, it is very important that the protein should be in its apo state. We thus measured the metal content by using inductively coupled plasma mass spectrometry. Our results showed that the protein samples did not contain any metal atoms and were indeed in the apo state (data not shown).
The thermodynamic parameters of equilibrium interaction between protein and ligand can be accurately determined by ITC [37] . ITC experiments were carried out to measure the interactions of Cu 2+ with HuPrP C (91-230) and RaPrP C (91-228) at pH 5.5 ( Fig. 1 and , the percentage of monomer was decreased significantly whereas the percentage of oligomer was increased markedly (Fig. 2A,B Monomeric PrP C and oligomeric PrP O adopted different conformations CD spectroscopy was applied to compare the secondary structures of monomeric and oligomeric PrPs ( Supplementary Fig. S2 ). The CD spectra indicated that both HuPrP C and RaPrP C adopted typical α-helical structures with well-defined negative peaks at 208 and 222 nm. However, the CD spectra showed one negative peak at 217 nm for HuPrP O perature (data not shown). In the absence of Cu 2+ , the far-UV CD spectra showed two negative peaks at 208 and 222 nm, indicating that both HuPrP C and RaPrP C adopted α-helix-rich structures (Fig. 3) . When 1 eq. of Cu 2+ was added, the CD spectrum of HuPrP C began to shift up (Fig. 3A) , whereas that of RaPrP C had a small shifting-down (Fig. 3B) . With the addition of Cu 2+ up to 4 eq., the CD spectra of HuPrP C shifted more significantly than those of RaPrP C . In the presence of 8-16 eq. of Cu 2+ , the CD spectra gradually became one negative peak at 217 nm, implying the generation of β-sheet-rich structure (Fig. 3A, right) . Compared with those of HuPrP C , the CD spectra of RaPrP C shifted up more slowly, although the characteristic of β-sheet-rich structure was observed with the addition of Cu 2+ up to 16 eq. (Fig. 3B, right) . Furthermore, the CD spectra of RaPrP C did not reach a roughly stable level-like HuPrP C even with the addition of 16 eq. of Cu 2+ (Fig. 3B, right) . These results indicated that Cu 2+ -binding can significantly change the secondary structures of both HuPrP C and RaPrP C , and induce the conformational conversion of PrP C from α-helix-rich structure to β-sheet-rich structure. The were performed by far-UV CD spectroscopy (Fig. 4) . Both HuPrP C and RaPrP C completely lost their secondary structures in the presence The effects of Cu 2+ -binding on the oligomerization of PrPsof 10 M urea. The apparent thermodynamic parameters of ureainduced unfolding transition for rabbit PrP C and its variants were described previously [33, 34] . C m is the concentration of urea required to denature 50% of a protein, and ΔG H2O N!U represents the apparent estimated free energy change of unfolding extrapolated to zero concentration of denaturant.
In the absence of Cu 2+ , the measured C m values of HuPrP C and RaPrP C were 5.37 ± 0.07 and 5.83 ± 0.09 M, respectively ( 
Discussion
Previous studies have demonstrated that the central nervous system has high level of copper [11, 12] and copper plays crucial roles in TSE diseases [38] [39] [40] [41] (Fig. 2) .
ITC experiments under acidic condition were conducted to mimic the environment in the endosomal-lysosomal system which is related to the pathogenesis of prion diseases [45] ) at pH 5.5. However, a previous study showed that Cu 2+ bound to mouse PrP C (91-231) with 10-fold higher affinity (10 6 M −1 ) at pH 6.6 [46] . Nevertheless, this study also showed that the affinity of Cu 2+ with PrP C was pH-dependent, and low pH could decrease the affinity of Cu 2+ with PrP C [46] . The affinity difference between our study and the previous study might be mostly due to the different pH conditions used. Furthermore, our ITC data showed that the affinity of HuPrP C (91-230) for Cu 2+ is higher than that of RaPrP C (91-228) ( Table 1) .
It could thus be speculated that HuPrP C (91-230) potentially underwent more significant conformational change than RaPrP C (91-228) due to Cu 2+ -binding (Fig. 3) . Previous works indicated that Cu 2+ mainly binds to the amyloid fragment of PrP C containing the residues His 95/96, His 110/111, and Met 108/109 [35, 36] . It has been suggested that the flexible region might make significant contribution to the misfolding of PrP and forming toxic agent [47] [48] [49] . Cu 2+ binding to PrP C would induce significant change in the spatial structure of this region and thereby promote the oligomerization of PrP C .
Jones et al. [50] found that Cu 2+ -binding to His-96 and His-111 resulted in an increase in β-sheet, which coupled with a loss of irregular structure in this fragment (residues 90-126) in PrP C . Our CD results indicated that Cu 2+ -binding promoted the conformational conversion of PrP C from α-helix-rich structure to β-sheet-rich structure at mild acidic environment ( pH 5.5; Fig. 3 ). Younan et al. [43] found that Cu 2+ -binding could lead to the loss of α-helical structures but could not induce the increase in β-sheet content of PrP (23-231) at neutral environment ( pH 7.4). These results may suggest that acidic environment facilitates Cu 2+ -binding-induced conformational change in PrP C [22] .
The ITC data indicated that Cu 2+ bound to HuPrP C (91-230) and RaPrP C (91-228) with moderate affinities ( Table 1) . The thermodynamic parameter derived from an ITC experiment includes contributions from all the events that might occur in the molecules going from free to bound state [51] , such as the protein structural change. Therefore, it is possible that our ITC results also include certain contributions made by some protein structural changes. Furthermore, no significant secondary structure change was detected in far-UV CD experiments when 1 eq. of Cu 2+ was added to either HuPrP C or RaPrP C (Fig. 3) . However, Cu 2+ -binding-induced conformational conversion of PrP C from α-helix-rich structure to β-sheet-rich structure was obviously observed when 8 eq. of Cu 2+ was added (Fig. 3) . The ITC data showed that the affinity of Cu 2+ for HuPrP C was higher than RaPrP C , probably explaining the observation that CD spectra of HuPrP C changed more significantly than those of RaPrP C when Cu 2+ was titrated to the PrP C solutions (Fig. 3) . These results showed that HuPrP C is more readily to change its conformation upon Cu 2+ -binding compared with (Fig. 4) , which might be due to the secondary structure changes induced by Cu 2+ -binding. Previous work demonstrated that Cu 2+ -binding-induced protein destabilization could facilitate the conformational conversion and oligomerization of PrP C [20, 52] . In the presence of Cu 2+ , the conformational stability of HuPrP C decreased more significantly than that of RaPrP C ( Table 2) . These results might explain the observation that the percentage of HuPrP O was increased more significantly in the presence of Cu 2+ than that of the RaPrP O (Fig. 2) .
In addition, we explored the conformational stabilities of oligomeric PrP O in the presence or in the absence of Cu 2+ by urea-induced unfolding transition experiments ( Supplementary Fig. S3 and Table S1 ). [53, 54] , which contradicted our results of this work. We think that the contradiction was resulted from different experimental conditions. The oligomers formed under different experimental conditions (pH, salt concentration, and denaturant) were pleomorphic [7, [55] [56] [57] , and could have somewhat different properties and possess different stabilities. In the previous studies, the prion oligomers were prepared in several days with denaturants (either urea or GdnHCl) under acidic conditions at room temperature (23°C). In the present study, oligomers were prepared by incubating proteins in the buffer without denaturants at 42°C, and obtained in much shorter time (80 min). It is expected that the stability of denaturant-induced oligomers is somewhat different from that of thermal-induced oligomers, and the status of denaturant-induced oligomers might be more similar to that of PrP Sc which is more stable than PrP C . Moreover, different buffers were used for the equilibrium denaturation of PrP in the previous studies and our study. In this study, we used the buffer without NaCl (20 mM NaOAc, pH 5.5) in urea-induced unfolding transition experiments, which could significantly reduce the thermodynamic stability of PrP C [58] , while in the previous studies, authors used the buffer with NaCl (20 mM NaOAc, 0.2 M NaCl, pH 3.6) [54] . . As well known, amyloid-β (Aβ) is responsible for Alzheimer's diseases due to its misfolding [59] . Previous works demonstrated that Cu 2+ could destabilize Aβ, promote protein oligomerization, and stabilize the Aβ oligomer [60, 61] . Cu 2+ enhances the stability of the Aβ oligomer by increasing the peptide-peptide binding forces [61] . It was further suggested that Cu 2+ could bridge the peptides in the oligomers and form a Aβ-Cu-Aβ-Cu-··· structure by binding to the His residues from the two peptides, and thereby stabilize the Aβ oligomer. Based on the previous results, we herein make a hypothesis that Cu 2+ could bridge monomeric PrP units in the PrP oligomer and form a PrP-Cu-PrP-Cu-··· structure. Nevertheless, further theoretically modeling and experimental studies are required to confirm this hypothesis. Based on our results, the mechanism by which Cu
2+
-binding promotes the oligomerization of PrP C in prion diseases could be described 
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